ATE203766T1 - Teil der intronsequenz des von hippel-lindau(vhl)-gens und seine verwendung zur krankheitsdiagnose - Google Patents
Teil der intronsequenz des von hippel-lindau(vhl)-gens und seine verwendung zur krankheitsdiagnoseInfo
- Publication number
- ATE203766T1 ATE203766T1 AT97917668T AT97917668T ATE203766T1 AT E203766 T1 ATE203766 T1 AT E203766T1 AT 97917668 T AT97917668 T AT 97917668T AT 97917668 T AT97917668 T AT 97917668T AT E203766 T1 ATE203766 T1 AT E203766T1
- Authority
- AT
- Austria
- Prior art keywords
- vhl
- gene
- lindau
- von hippel
- disease diagnosis
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57575—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Apparatus For Radiation Diagnosis (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/623,428 US6312890B1 (en) | 1993-05-14 | 1996-03-28 | Partial intron sequence of von hippel-lindau (VHL) disease gene and its use in diagnosis of disease |
| PCT/US1997/005059 WO1997035978A1 (en) | 1996-03-28 | 1997-03-27 | Partial intron sequence of von hippel-lindau (vhl) disease gene and its use in diagnosis of disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE203766T1 true ATE203766T1 (de) | 2001-08-15 |
Family
ID=24498052
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97917668T ATE203766T1 (de) | 1996-03-28 | 1997-03-27 | Teil der intronsequenz des von hippel-lindau(vhl)-gens und seine verwendung zur krankheitsdiagnose |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6312890B1 (de) |
| EP (1) | EP0889959B1 (de) |
| JP (1) | JP2000507823A (de) |
| AT (1) | ATE203766T1 (de) |
| AU (1) | AU2593197A (de) |
| CA (1) | CA2250452A1 (de) |
| DE (1) | DE69705936D1 (de) |
| WO (1) | WO1997035978A1 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7078174B1 (en) | 1998-12-21 | 2006-07-18 | The Walter & Eliza Hall Institute Of Medical Research | Screening methods using SOCS box-containing peptides |
| WO2002012567A1 (en) * | 2000-08-09 | 2002-02-14 | Dzgenes, Llc | Vhl promoter diagnostic polymorphism |
| US20040166491A1 (en) * | 2001-08-09 | 2004-08-26 | Henderson Lee A | Vhl promoter diagnostic polymorphism |
| US20050208023A1 (en) * | 2002-07-19 | 2005-09-22 | Krissansen Geoffrey W | Tumor treating composition and methods |
| US20060134708A1 (en) * | 2004-10-14 | 2006-06-22 | Northwestern University | Detection and treatment of renal cancer |
| US7549447B1 (en) * | 2007-12-01 | 2009-06-23 | Joe Garbo | Pressure valve inlet cover system |
| KR101064603B1 (ko) | 2008-11-13 | 2011-09-15 | 한국생명공학연구원 | 리포터 시스템을 이용한 메틸트렌스퍼레이즈 저해 물질 스크리닝 방법 |
| US9637796B2 (en) | 2011-11-17 | 2017-05-02 | The Johns Hopkins University | Differential identification of pancreatic cysts |
| ES2694296T3 (es) * | 2014-06-17 | 2018-12-19 | Centre National De La Recherche Scientifique (Cnrs) | Anticuerpos monoclonales anti-pVHL y usos de los mismos |
| CN105063231A (zh) * | 2015-09-15 | 2015-11-18 | 北京大学第一医院 | 一种羊水中胎儿细胞vhl基因突变检测方法及试剂盒 |
| CN105087809A (zh) * | 2015-09-15 | 2015-11-25 | 北京大学第一医院 | 一种快速检测羊水中胎儿细胞vhl基因突变的方法及试剂盒 |
| CN105112532A (zh) * | 2015-09-15 | 2015-12-02 | 北京大学第一医院 | 一种检测vhl基因大片段缺失的杂交探针及检测方法与试剂盒 |
| CN105087808A (zh) * | 2015-09-15 | 2015-11-25 | 北京大学第一医院 | 一种检测vhl基因突变的方法及试剂盒 |
| CN113913529A (zh) * | 2021-12-01 | 2022-01-11 | 济南艾迪康医学检验中心有限公司 | 检测VHL基因c.-195G>A位点突变的方法、引物和试剂盒 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5654138A (en) * | 1993-05-14 | 1997-08-05 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Von hippel-lindau (VHL) disease gene and corresponding cDNA and methods for detecting carriers of the VHL disease gene |
-
1996
- 1996-03-28 US US08/623,428 patent/US6312890B1/en not_active Expired - Lifetime
-
1997
- 1997-03-27 WO PCT/US1997/005059 patent/WO1997035978A1/en not_active Ceased
- 1997-03-27 JP JP9534644A patent/JP2000507823A/ja active Pending
- 1997-03-27 DE DE69705936T patent/DE69705936D1/de not_active Expired - Lifetime
- 1997-03-27 CA CA002250452A patent/CA2250452A1/en not_active Abandoned
- 1997-03-27 EP EP97917668A patent/EP0889959B1/de not_active Expired - Lifetime
- 1997-03-27 AT AT97917668T patent/ATE203766T1/de not_active IP Right Cessation
- 1997-03-27 AU AU25931/97A patent/AU2593197A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US6312890B1 (en) | 2001-11-06 |
| AU2593197A (en) | 1997-10-17 |
| WO1997035978A1 (en) | 1997-10-02 |
| JP2000507823A (ja) | 2000-06-27 |
| DE69705936D1 (de) | 2001-09-06 |
| EP0889959B1 (de) | 2001-08-01 |
| EP0889959A1 (de) | 1999-01-13 |
| CA2250452A1 (en) | 1997-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE203766T1 (de) | Teil der intronsequenz des von hippel-lindau(vhl)-gens und seine verwendung zur krankheitsdiagnose | |
| ATE241977T1 (de) | Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen | |
| ATE275383T1 (de) | Oxadisäuren und verwandte verbindungen zur behandlung von hautstörungen | |
| ATE279181T1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
| ATE255902T1 (de) | Ein anti-idiotypischer antikörper und seine verwendung in der diagnose und therapie von hiv- verwandten krankheiten | |
| DE69836752D1 (de) | Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen | |
| DE3579113D1 (de) | Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden. | |
| ATE182180T1 (de) | Lamanin-ketten: diagnostische und therapeutische verwendung | |
| DE69918687D1 (de) | 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen | |
| ATE311853T1 (de) | Verwendung von krillenzymen zur behandlung von zahnbelag | |
| GR3030876T3 (en) | VON HIPPEL-LINDAU (VHL) DISEASE GENE AND CORRESPONDING cDNA AND METHODS FOR DETECTING CARRIERS OF THE VHL DISEASE GENE | |
| DE69840752D1 (de) | Verwendung von coumarine zur behandlung von lebererkrankungen und pankreaserkrankungen | |
| EP0871457A4 (de) | Isolierte stromazellen und methoden zu deren verwendung | |
| ATE88500T1 (de) | Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel. | |
| DE60035693D1 (de) | Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten | |
| ATE173620T1 (de) | Verwendung eines antagonisten von tnf-alpha zur behandlung von hautrötungen neurogenen ursprungs | |
| DE69510356D1 (de) | Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie | |
| Raza et al. | A novel homozygous nonsense mutation in the PVRL4 gene and expansion of clinical spectrum of EDSS1 | |
| ATE313561T1 (de) | Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen | |
| ATE375389T1 (de) | Verfahren zur diagnose, prognose und behandlung von glaukom und verwandten erkrankungen | |
| DE69827805D1 (de) | Verfahren und vorrichtung zur bestimmung des transformationspotentials von verbindungen. | |
| DE3688528D1 (de) | Optische analoge datenverarbeitungsanordnungen zur behandlung von bipolaren und komplexen daten. | |
| EP1009768A4 (de) | Persephin und verwandte wachstumsfaktoren | |
| DE69729735D1 (de) | Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen | |
| GB9610281D0 (en) | Diagnostic method and apparatus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |